Dr. Andrew Rut, CEO of MyMeds&Me speaks to The Pharma Letter
Is Big Data Always Good Data?
MyMeds&Me attend DIA Global Meeting 2018 in Boston
Dr. Andrew Rut, CEO of MyMeds&Me, will be speaking at FutureLink Conference in Munich
Andrew Rut, CEO of MyMeds&Me shares his thoughts on Brexit’s impact on clinical trials
New big data rules threaten effective drug development
New ‘tech’ on the block: The critical role of new tech in advancing patient autonomy and drug development.
Andrew Rut, CEO of MyMeds&Me, speaks to the Pharmaceutical Journal
For expert insight and updates from the MyMeds&Me team.
We respect your privacy and we will only use your email address for newsletters and company updates
To find out more or request a demo fill in the details below: